Chemical formula: C₂₁H₂₁NO₂S Molecular mass: 351.462 g/mol PubChem compound: 5381
Tazarotene is indicated for:
Population group: only adults (18 - 65 years old)
Tazarotene is indicated for the topical treatment of mild to moderate plaque psoriasis involving up to 10% body surface area.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Tazarotene is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
